|
Hepatitis B
|
0.100 |
Biomarker
|
disease |
BEFREE |
42% (15 of 21 specimens), but there was only 40% positivity (8 of 20 specimens) for hepatitis B virus envelope antigen whereas 6 of 17 patients (35.29%) showed the presence of antibodies against hepatitis B virus envelope protein.
|
10738214 |
2000 |
|
Canarypox (disorder)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Canarypox (CP) and fowlpox (FP) constructs, containing the complete env gene (IS(+)) from the HIV-1(SF2) strain, induced a higher profile of epitope recognition than their counterparts expressing the env gene deleted of the putative immunosuppressive region (IS(-)).
|
10683465 |
2000 |
|
Hepatitis C
|
0.100 |
Biomarker
|
disease |
BEFREE |
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
|
12615904 |
2003 |
|
Hepatitis A
|
0.030 |
Biomarker
|
disease |
BEFREE |
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
|
12615904 |
2003 |
|
Influenza
|
0.090 |
Biomarker
|
disease |
BEFREE |
Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
|
16397505 |
2006 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.100 |
Biomarker
|
disease |
BEFREE |
Human immunodeficiency virus type 1 (HIV-1) env genes were cloned from blood samples of HIV-1-infected Thai patients, and 35 infectious CRF01_AE envelope glycoprotein (Env)-recombinant viruses were established.
|
19136072 |
2009 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.100 |
Biomarker
|
disease |
BEFREE |
Human immunodeficiency virus type 1 (HIV-1) envelope protein (Env) is subject to both neutralizing antibody (NAb) and CD8 T-cell (cytotoxic T-lymphocyte [CTL]) immune pressure.
|
19515763 |
2009 |
|
Severe Acute Respiratory Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis.
|
22028656 |
2011 |
|
Influenza
|
0.090 |
Biomarker
|
disease |
BEFREE |
Influenza virus hemagglutinin (HA) is the viral envelope protein that mediates viral attachment to host cells and elicits membrane fusion.
|
22072785 |
2012 |
|
Dengue Fever
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
|
23993978 |
2013 |
|
West Nile viral infection
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
West Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles.
|
24049184 |
2013 |
|
Influenza
|
0.090 |
Biomarker
|
disease |
BEFREE |
Influenza vaccines must be frequently reformulated to account for antigenic changes in the viral envelope protein, hemagglutinin (HA).
|
26739054 |
2016 |
|
Hepatitis C
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine.
|
26742442 |
2015 |
|
Herpes Simplex Infections
|
0.070 |
Biomarker
|
group |
BEFREE |
Herpes simplex virus spread between epithelial cells is mediated by virus tegument and envelope protein complexes including gE/gI and pUL51/pUL7. pUL51 interacts with both pUL7 and gE/gI in infected cells.
|
31493658 |
2019 |
|
HIV-1 infection
|
0.100 |
Biomarker
|
disease |
BEFREE |
HIV-1 infection of a human T-cell line transduced with this vector led to induction of sCD4-KDEL synthesis and a block in transport of the HIV envelope protein to the cell surface.
|
8464877 |
1993 |
|
West Nile viral infection
|
0.100 |
Biomarker
|
disease |
BEFREE |
Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.
|
15956579 |
2005 |
|
Dengue Fever
|
0.100 |
Biomarker
|
disease |
BEFREE |
Envelope protein gene sequences of all four dengue serotypes (DENV-1-DENV-4) obtained from human sera in Singapore (2008-2010) revealed that constant viral introductions and in situ evolution contribute to viral diversity in Singapore and play important roles in shaping the epidemiology of dengue in the island state.
|
22036707 |
2012 |
|
Japanese Encephalitis
|
0.070 |
Biomarker
|
disease |
BEFREE |
Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
|
23927571 |
2013 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A 240-bp DNA fragment encoding a peptide, designated ENV(80), homologous to a conserved part of the gp41 transmembrane glycoprotein of human immunodeficiency virus (HIV) was chemically synthesized and inserted into different plasmid expression vectors.
|
3491755 |
1986 |
|
Hepatitis C
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2.
|
11675335 |
2001 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.100 |
Biomarker
|
disease |
BEFREE |
A 700-bp fragment of the human immunodeficiency virus type 1 (HIV-1) env gene, including the V3-V5 region, was successfully amplified by PCR from 10 samples (52.6%) and was subsequently subjected to both a heteroduplex mobility assay for genetic screening and subtyping and DNA sequence analysis (approximately 300 bp) for nucleotide comparison and phylogenetic studies.
|
7494310 |
1995 |
|
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
A chimeric simian-human immunodeficiency virus (SHIV-4) containing the tat, rev, vpu, and env genes of HIV type 1 (HIV-1) in a genetic background of SIVmac239 was used to develop an animal model in which a primate lentivirus expressing the HIV-1 envelope glycoprotein caused acquired immune deficiency syndrome (AIDS) in macaques.
|
10087226 |
1999 |
|
West Nile viral infection
|
0.100 |
Biomarker
|
disease |
BEFREE |
A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines.
|
31300121 |
2019 |
|
Tick-Borne Encephalitis
|
0.060 |
Biomarker
|
disease |
BEFREE |
A comparative analysis on the physicochemical properties of tick-borne encephalitis virus envelope protein residues that affect its antigenic properties.
|
28625666 |
2017 |
|
West Nile viral infection
|
0.100 |
Biomarker
|
disease |
BEFREE |
A DNA plasmid was constructed encoding an SCT incorporating the human MHC class I molecule HLA-A2 and the immunodominant peptide SVG9 derived from the envelope protein of West Nile virus (WNV).
|
20212098 |
2010 |